Bio-Techne
TECH
549 hedge funds and large institutions have $11.1B invested in Bio-Techne in 2023 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 218 increasing their positions, 185 reducing their positions, and 58 closing their positions.
150% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $6.19M
22% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 58
18% more repeat investments, than reductions
Existing positions increased: 218 | Existing positions reduced: 185
1% more funds holding
Funds holding: 545 → 549 (+4)
0.76% less ownership
Funds ownership: 95.51% → 94.76% (-0.76%)
11% less capital invested
Capital invested by funds: $12.4B → $11.1B (-$1.4B)
55% less funds holding in top 10
Funds holding in top 10: 11 → 5 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$64.8M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$43.7M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$40.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$39.4M |
| 5 |
Millennium Management
New York
|
+$32.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$261M |
| 2 |
Select Equity Group
New York
|
-$117M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$80.4M |
| 4 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
-$71M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$57.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RBC
601
Romano Brothers & Co
Evanston,
Illinois
| – | -$5.97K | -72 | Closed |
|
602
First Manhattan
New York
| – | -$4.64K | -56 | Closed |
|
|
VCM
603
Vigilant Capital Management
Portland,
Maine
| – | -$4K | -48 | Closed |
|
|
MDCM
604
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
| – | -$2.65K | -32 | Closed |
|
|
AWM
605
Accurate Wealth Management
Wesley Chapel,
Florida
| – | -$1.47K | -17 | Closed |
|
|
BAAM
606
Baker Avenue Asset Management
San Francisco,
California
| – | -$995 | -12 | Closed |
|
|
CFO
607
CVA Family Office
Denver,
Colorado
| – | -$414 | -5 | Closed |
|
|
SIA
608
SkyView Investment Advisors
Shrewsbury,
New Jersey
| – | +$308 | +4 | New |
|
TECH Hedge Fund Activity: Q1 2023 in Review
549 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2023, worth a combined $11.1B — down 11% from $12.4B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new TECH positions and 58 closed out — a net gain of 13 holders — while 218 added to existing stakes and 185 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $64.8M. The largest seller was Winslow Capital Management, exiting entirely with an estimated $261M sold.
- 549 institutional investors held Bio-Techne (TECH) as of Q1 2023, up from 545 in Q4 2022.
- Funds reported $11.1B of Bio-Techne stock for Q1 2023, down 11% quarter-over-quarter.
- 71 funds opened new Bio-Techne positions in Q1 2023 and 58 closed out, a net change of +13 holders.
- The largest Bio-Techne buyer in Q1 2023 was Point72 Asset Management, an estimated $64.8M added.
- The largest Bio-Techne seller in Q1 2023 was Winslow Capital Management, an estimated $261M sold.
Based on aggregated 13F filings for Q1 2023.